clinical trials

2022 ASCO Annual Meeting; #ASCO22
May 26, 2022 · Greg Guthrie, ASCO Staff
La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) de 2022 se llevará a cabo del 3 al 7 de junio. En esta publicación inicial de la investigación que se presenta en la reunión, los estudios examinan cómo la raza, el origen étnico, la pobreza y otros factores sociales y demográficos afectan la vida de las personas con cáncer. Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022 · Greg Guthrie, ASCO Staff
The 2022 ASCO Annual Meeting is being held June 3 to 7. In this early release of research being presented at the meeting, studies examine how race, ethnicity, poverty, and other social and demographic factors affect the lives of people with cancer. Read More >>
December 21, 2021 · Jyoti Patel, MD, FASCO
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses the disparities that exist in cancer clinical trials and how cancer care providers are working to address the barriers to participation in clinical trials for minority populations. Read More >>
June 10, 2021 · Patty Spears
Patient advocate Patty Spears discusses what eligibility criteria for cancer clinical trials are, why they’re important to cancer research, and how eligibility criteria are changing to include more people with cancer in clinical trials. Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021 · ASCO Staff
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer. Read More >>

Pages